Laboratory of Molecular Immunology and Immunotherapy
Monica S. Thakar has not added Biography.
If you are Monica S. Thakar and would like to personalize this page please email our Author Liaison for assistance.
Biodistributions, myelosuppression, and toxicities in mice treated with an anti-CD45 antibody labeled with the alpha-emitting radionuclides bismuth-213 or astatine-211.
Cancer research Mar, 2009 | Pubmed ID: 19244101
Transmission and expansion of HOXB4-induced leukemia in two immunosuppressed dogs: implications for a new canine leukemia model.
Experimental hematology Oct, 2009 | Pubmed ID: 19616601
Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine.
Bioconjugate chemistry Oct, 2009 | Pubmed ID: 19731929
ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program , 2009 | Pubmed ID: 20008227
Plerixafor-moblized stem cells alone are capable of inducing early engraftment across the MHC-haploidentical canine barrier.
Blood Jan, 2010 | Pubmed ID: 20110438
Evaluation of posttransplant methotrexate to facilitate engraftment in the canine major histocompatibility complex-haploidentical nonmyeloablative transplant model.
Transplantation Jul, 2010 | Pubmed ID: 20626083
Transforming growth factor-beta-activated kinase 1 regulates natural killer cell-mediated cytotoxicity and cytokine production.
The Journal of biological chemistry Sep, 2011 | Pubmed ID: 21771792
Immunomodulatory effects induced by cytotoxic T lymphocyte antigen 4 immunoglobulin with donor peripheral blood mononuclear cell infusion in canine major histocompatibility complex-haplo-identical non-myeloablative hematopoietic cell transplantation.
Cytotherapy Nov, 2011 | Pubmed ID: 21846291
Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia.
Pediatric hematology and oncology Sep, 2012 | Pubmed ID: 22839094
Pawan Kumar1,
Allison E. Bartoszek1,
Thomas M. Moran2,
Jack Gorski3,
Sanjib Bhattacharyya4,
Jose F. Navidad4,
Monica S. Thakar1,5,
Subramaniam Malarkannan1,6
1Laboratory of Molecular Immunology and Immunotherapy, Blood Research Institute,
2Department of Microbiology, Mount Sinai School of Medicine ,
3Laboratory of Molecular Genetics, Blood Research Institute,
4, City of Milwaukee Health Department Laboratory,
5Division of Hematology-Oncology/BMT, Children's Hospital of Wisconsin, Medical College of Wisconsin ,
6Division of Hematology and Oncology, Dept Medicine, Medical College of Wisconsin
Arash Nanbakhsh1,
Brad Best2,
Matthew Riese3,
Sridhar Rao4,
Li Wang5,
Jeffrey Medin6,
Monica S. Thakar6,
Subramaniam Malarkannan1,5,6,7
1Laboratory of Molecular Immunology and Immunotherapy, Blood Research Institute, The Blood Center of Wisconsin,
2Vector Core Lab, Blood Research Institute, The Blood Center of Wisconsin,
3Laboratory of Lymphocyte Biology, Blood Research Institute, The Blood Center of Wisconsin,
4Laboratory of Stem Cell Transcriptional Regulation, Blood Research Institute, The Blood Center of Wisconsin,
5Department of Microbiology and Immunology, The Medical College of Wisconsin,
6Department of Pediatrics, The Medical College of Wisconsin,
7Department of Medicine, The Medical College of Wisconsin
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。